Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results
2006

Managing Locally Advanced Cervical Cancer with Chemoradiation

Sample size: 294 publication Evidence: moderate

Author Information

Author(s): Cetina Lucely, Rivera Lesbia, Hinojosa José, Poitevin Adela, Uribe Jesús, López-Graniel Carlos, Cantú David, Candelaria Myrna, de la Garza Jaime, Dueñas-González Alfonso

Primary Institution: Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

Hypothesis

Can the results of cisplatin-based chemoradiation for cervical cancer be replicated in a community setting?

Conclusion

The study supports the use of chemoradiation with six weekly applications of cisplatin for managing locally advanced cervical cancer.

Supporting Evidence

  • 83% of patients achieved complete responses to treatment.
  • Overall survival rate was 76.5% at a median follow-up of 28 months.
  • 96% of patients completed the planned radiation therapy.

Takeaway

Doctors treated 294 women with cervical cancer using radiation and a medicine called cisplatin, and most of them got better.

Methodology

The study reviewed the files of 294 patients treated with radiation and weekly cisplatin from 1999 to 2003, analyzing treatment compliance, response rate, toxicity, and survival.

Potential Biases

Potential bias due to the retrospective nature and lack of randomization.

Limitations

The study is retrospective and conducted in a single institution, which may limit generalizability.

Participant Demographics

Mean age was 43.8 years, with the majority being squamous cell carcinoma cases.

Digital Object Identifier (DOI)

10.1186/1472-6874-6-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication